Tyrosine Kinase Inhibitor Therapy Induces Remission in a Patient With Refractory EBF1-PDGFRB–Positive Acute Lymphoblastic Leukemia
Year: 2013
Type: article
Source: Journal of Clinical Oncology
Authors: Brent W. Weston, Melissa A. Hayden, Kathryn G. Roberts, Susan Bowyer, Johann Hsu, George Fedoriw, Kathleen W. Rao, Charles G. Mullighan
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2037104393
